Researchers unveiled UMBS‑seq (Ultra‑Mild Bisulfite Sequencing), a gentler methylation assay that preserves degraded DNA while delivering accurate methylation calls—addressing long‑standing limitations of conventional bisulfite methods for old or precious samples. The technique improves coverage and reduces sequence artefacts, enabling methylation analysis from older clinical archives and expanding opportunities for retrospective biomarker discovery and epigenetic diagnostics.